Arcturus Therapeutics Holdings, Inc. (ARCT)
7.45
-0.15
(-1.97%)
USD |
NASDAQ |
Nov 20, 16:00
7.42
-0.03
(-0.40%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Total Assets (Quarterly) : 215.32M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 215.32M |
| June 30, 2026 | 224.31M |
| March 31, 2026 | 245.41M |
| December 31, 2025 | 271.15M |
| September 30, 2025 | 282.34M |
| June 30, 2025 | 309.27M |
| March 31, 2025 | 331.78M |
| December 31, 2024 | 344.07M |
| September 30, 2024 | 370.65M |
| June 30, 2024 | 388.61M |
| March 31, 2024 | 418.85M |
| December 31, 2023 | 429.40M |
| September 30, 2023 | 457.65M |
| June 30, 2023 | 430.65M |
| March 31, 2023 | 470.86M |
| December 31, 2022 | 450.39M |
| September 30, 2022 | 293.63M |
| June 30, 2022 | 337.01M |
| March 31, 2022 | 341.99M |
| December 31, 2021 | 392.81M |
| September 30, 2021 | 434.54M |
| June 30, 2021 | 448.81M |
| March 31, 2021 | 481.47M |
| December 31, 2020 | 476.46M |
| September 30, 2020 | 322.52M |
| Date | Value |
|---|---|
| June 30, 2020 | 149.94M |
| March 31, 2020 | 72.10M |
| December 31, 2019 | 82.14M |
| September 30, 2019 | 87.22M |
| June 30, 2019 | 70.94M |
| March 31, 2019 | 44.42M |
| December 31, 2018 | 44.20M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 52.02M |
| September 30, 2017 | 40.59M |
| June 30, 2017 | 42.35M |
| March 31, 2017 | 46.42M |
| December 31, 2016 | 51.57M |
| September 30, 2016 | 55.91M |
| June 30, 2016 | 62.69M |
| March 31, 2016 | 67.10M |
| December 31, 2015 | 71.68M |
| September 30, 2015 | 37.65M |
| June 30, 2015 | 41.62M |
| March 31, 2015 | |
| December 31, 2014 | 22.32M |
| September 30, 2014 | 30.86M |
| June 30, 2014 | 40.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Emergent BioSolutions, Inc. | 995.20M |
| Ionis Pharmaceuticals, Inc. | 2.913B |
| United Therapeutics Corp. | 7.034B |
| Ocugen, Inc. | 108.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.59M |
| Shareholders Equity (Quarterly) | 168.73M |
| Debt to Equity Ratio | 0.1296 |
| Current Ratio | 6.682 |
| Net Debt Paydown Yield | 0.26% |